Sanofi India · NSE: SANOFI · BSE: 500674
Q2 FY24 results · Jul–Sep 2023
Sanofi India reported revenue from operations of ₹714.58 crore and net profit of ₹151.95 crore for Q2 FY24 (Jul–Sep 2023), on a consolidated basis.
| Item | Q2 FY24 | Q2 FY23 | YoY | Q1 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 714.58 | — | — | 706.10 | +1.2% |
| Other income | 11.82 | — | — | 15.70 | −24.7% |
| Total income | 726.40 | — | — | 721.80 | +0.6% |
| Profit before tax | 209.88 | — | — | 183.40 | +14.4% |
| Net profit for the period | 151.95 | — | — | 122.90 | +23.6% |
| EPS, basic (₹) | 65.95 | — | — | 53.37 | +23.6% |
| Net margin (%) | 21.3 | — | 17.4 |
| Item | Q2 FY24 | Q2 FY23 | YoY | Q1 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 714.58 | 691.90 | +3.3% | 706.10 | +1.2% |
| Other income | 11.82 | 11.40 | +3.7% | 15.70 | −24.7% |
| Total income | 726.40 | 703.30 | +3.3% | 721.80 | +0.6% |
| Profit before tax | 210.07 | 182.40 | +15.2% | 183.40 | +14.5% |
| Net profit for the period | 152.14 | 130.90 | +16.2% | 122.90 | +23.8% |
| EPS, basic (₹) | 66.08 | 56.84 | +16.3% | 53.37 | +23.8% |
| Net margin (%) | 21.3 | 18.9 | 17.4 |
Consolidated
- Filed with BSE
- 10 Nov 2023, 16:14 IST
- Board meeting
- 08 Nov 2023
- Period
- 01 Jul 2023 to 30 Sep 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 10 Nov 2023, 16:14 IST
- Board meeting
- 08 Nov 2023
- Period
- 01 Jul 2023 to 30 Sep 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE